Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Mesalamine"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 2916
Tytuł:
Synthesis and Bioactive Properties of the Novel Coloured Compound Obtained via the Laccase-Mediated Transformation of 5-Aminosalicylic Acid.
Autorzy:
Polak J; Department of Biochemistry and Biotechnology, Institute of Biological Sciences, Maria Curie-Skłodowska University, 20-031 Lublin, Poland.
Grąz M; Department of Biochemistry and Biotechnology, Institute of Biological Sciences, Maria Curie-Skłodowska University, 20-031 Lublin, Poland.
Szałapata K; Department of Biochemistry and Biotechnology, Institute of Biological Sciences, Maria Curie-Skłodowska University, 20-031 Lublin, Poland.
Kapral-Piotrowska J; Department of Functional Anatomy and Cytobiology, Institute of Biological Sciences, Maria Curie-Skłodowska University, 20-031 Lublin, Poland.
Wlizło K; Department of Industrial and Environmental Microbiology, Institute of Biological Sciences, Maria Curie-Skłodowska University, 20-031 Lublin, Poland.
Polak M; Department of Zoology and Nature Protection, Institute of Biological Sciences, Maria Curie-Skłodowska University, 20-031 Lublin, Poland.
Jarosz-Wilkołazka A; Department of Biochemistry and Biotechnology, Institute of Biological Sciences, Maria Curie-Skłodowska University, 20-031 Lublin, Poland.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2024 Mar 15; Vol. 29 (6). Date of Electronic Publication: 2024 Mar 15.
Typ publikacji:
Journal Article
MeSH Terms:
Laccase*/metabolism
Mesalamine*/pharmacology
Animals ; Oxidation-Reduction ; Antioxidants/chemistry ; Coloring Agents/chemistry ; Hydrogen-Ion Concentration
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
An In Vitro Study Evaluating the Safety of Mesalazine on Human Nasoepithelial Cells.
Autorzy:
Murphy W; Department of Surgery-Otolaryngology Head and Neck Surgery, Basil Hetzel Institute for Translational Health Research, Central Adelaide Local Health Network, Adelaide 5011, Australia.; The Department of Surgery, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide 5000, Australia.
Liu S; Department of Surgery-Otolaryngology Head and Neck Surgery, Basil Hetzel Institute for Translational Health Research, Central Adelaide Local Health Network, Adelaide 5011, Australia.; The Department of Surgery, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide 5000, Australia.
Javadiyan S; Department of Surgery-Otolaryngology Head and Neck Surgery, Basil Hetzel Institute for Translational Health Research, Central Adelaide Local Health Network, Adelaide 5011, Australia.; The Department of Surgery, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide 5000, Australia.
Vyskocil E; Department of Surgery-Otolaryngology Head and Neck Surgery, Basil Hetzel Institute for Translational Health Research, Central Adelaide Local Health Network, Adelaide 5011, Australia.; Department of Otolaryngology, Head and Neck Surgery, Medical University of Vienna, 1090 Vienna, Austria.
Feizi S; Department of Surgery-Otolaryngology Head and Neck Surgery, Basil Hetzel Institute for Translational Health Research, Central Adelaide Local Health Network, Adelaide 5011, Australia.; The Department of Surgery, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide 5000, Australia.
Callejas C; Department of Otolaryngology, Head and Neck Surgery, The Ohio State University, Columbus, OH 43210, USA.; Department of Otolaryngology, Pontificia Universidad Católica de Chile, Santiago 8320165, Chile.
Wormald PJ; Department of Surgery-Otolaryngology Head and Neck Surgery, Basil Hetzel Institute for Translational Health Research, Central Adelaide Local Health Network, Adelaide 5011, Australia.; The Department of Surgery, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide 5000, Australia.
Vreugde S; Department of Surgery-Otolaryngology Head and Neck Surgery, Basil Hetzel Institute for Translational Health Research, Central Adelaide Local Health Network, Adelaide 5011, Australia.; The Department of Surgery, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide 5000, Australia.
Psaltis AJ; Department of Surgery-Otolaryngology Head and Neck Surgery, Basil Hetzel Institute for Translational Health Research, Central Adelaide Local Health Network, Adelaide 5011, Australia.; The Department of Surgery, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide 5000, Australia.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Feb 28; Vol. 25 (5). Date of Electronic Publication: 2024 Feb 28.
Typ publikacji:
Journal Article
MeSH Terms:
Mesalamine*/therapeutic use
Sinusitis*/metabolism
Humans ; Tumor Necrosis Factor-alpha/metabolism ; Cells, Cultured ; Nasal Mucosa/metabolism ; Interleukin-6/metabolism ; Anti-Inflammatory Agents/pharmacology ; Chronic Disease ; Epithelial Cells/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Pharmacokinetic and safety profiles of mesalazine enema in healthy Chinese subjects: A single- and multiple-dose study.
Autorzy:
Cao Y; Clinical Trial Institute, Huashan Hospital, Fudan University, Shanghai, China.
Wang J; Phase I Clinical Research Center, Huashan Hospital, Fudan University, Shanghai, China.
Tang X; Phase I Clinical Research Center, Huashan Hospital, Fudan University, Shanghai, China.
Tian Y; Phase I Clinical Research Center, Huashan Hospital, Fudan University, Shanghai, China.
Yu J; Phase I Clinical Research Center, Huashan Hospital, Fudan University, Shanghai, China.
Liang H; Phase I Clinical Research Center, Huashan Hospital, Fudan University, Shanghai, China.
Wu J; Phase I Clinical Research Center, Huashan Hospital, Fudan University, Shanghai, China.
Chen Y; Phase I Clinical Research Center, Huashan Hospital, Fudan University, Shanghai, China.
Cao G; Clinical Trial Institute, Huashan Hospital, Fudan University, Shanghai, China.; Phase I Clinical Research Center, Huashan Hospital, Fudan University, Shanghai, China.
Zhang J; Phase I Clinical Research Center, Huashan Hospital, Fudan University, Shanghai, China.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Feb 02; Vol. 19 (2), pp. e0296940. Date of Electronic Publication: 2024 Feb 02 (Print Publication: 2024).
Typ publikacji:
Clinical Trial; Journal Article
MeSH Terms:
Mesalamine*/adverse effects
Tandem Mass Spectrometry*/methods
Humans ; Administration, Oral ; Area Under Curve ; China ; Chromatography, Liquid ; Dose-Response Relationship, Drug ; Healthy Volunteers
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Oxidation of Mesalamine under Phenoloxidase- or Peroxidase-like Enzyme Catalysis.
Autorzy:
El Zein R; Department of Chemistry and Center CERMO-FC, Université du Québec à Montréal, Downtown Branch, P.O. Box 8888, Montréal, QC H3C 3P8, Canada.
Ispas-Szabo P; Department of Chemistry and Center CERMO-FC, Université du Québec à Montréal, Downtown Branch, P.O. Box 8888, Montréal, QC H3C 3P8, Canada.
Jafari M; Department of Chemistry and Center CERMO-FC, Université du Québec à Montréal, Downtown Branch, P.O. Box 8888, Montréal, QC H3C 3P8, Canada.
Siaj M; Department of Chemistry and Center CERMO-FC, Université du Québec à Montréal, Downtown Branch, P.O. Box 8888, Montréal, QC H3C 3P8, Canada.
Mateescu MA; Department of Chemistry and Center CERMO-FC, Université du Québec à Montréal, Downtown Branch, P.O. Box 8888, Montréal, QC H3C 3P8, Canada.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2023 Dec 15; Vol. 28 (24). Date of Electronic Publication: 2023 Dec 15.
Typ publikacji:
Journal Article
MeSH Terms:
Mesalamine*/chemistry
Colitis, Ulcerative*/drug therapy
Humans ; Monophenol Monooxygenase ; Hydroquinones ; Anti-Inflammatory Agents, Non-Steroidal/chemistry ; Peroxidase ; Oxidation-Reduction ; Peroxidases ; Quinones/therapeutic use ; Catalysis ; Imines
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Investigation of mesalazine as an antifibrotic drug following myocardial infarction in male mice.
Autorzy:
Künzel SR; Institute of Pharmacology and Toxicology, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; Institute of Transfusion Medicine, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; German Red Cross Blood Donation Service North-East, Dresden, Germany.
Winter L; Institute of Pharmacology and Toxicology, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Hoffmann M; Institute of Pharmacology and Toxicology, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Kant TA; Institute of Pharmacology and Toxicology, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Thiel J; Institute of Transfusion Medicine, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; German Red Cross Blood Donation Service North-East, Dresden, Germany.
Kronstein-Wiedemann R; Institute of Transfusion Medicine, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; German Red Cross Blood Donation Service North-East, Dresden, Germany.
Klapproth E; Institute of Pharmacology and Toxicology, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Lorenz K; Institute of Pharmacology and Toxicology, Julius-Maximilians-University of Würzburg, Würzburg, Germany.; Leibniz-Institut für Analytische Wissenschaften -ISAS- e.V, Dortmund, Germany.
El-Armouche A; Institute of Pharmacology and Toxicology, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Kämmerer S; Institute of Pharmacology and Toxicology, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Pokaż więcej
Źródło:
Physiological reports [Physiol Rep] 2023 Sep; Vol. 11 (17), pp. e15809.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Mesalamine*/pharmacology
Mesalamine*/therapeutic use
Myocardial Infarction*/drug therapy
Male ; Animals ; Mice ; Mice, Inbred C57BL ; Heart ; Myocardium
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Drug-induced bradycardia.
Autorzy:
Gn D; St John's Medical College Hospital, Bengaluru, India .
Patil M; St John's Medical College Hospital, Bengaluru, India.
Shafiq S; St John's Medical College Hospital, Bengaluru, India.
Pokaż więcej
Źródło:
Clinical medicine (London, England) [Clin Med (Lond)] 2023 Mar; Vol. 23 (2), pp. 173-174.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Mesalamine*/adverse effects
Colitis, Ulcerative*/drug therapy
Female ; Humans ; Middle Aged ; Anti-Inflammatory Agents, Non-Steroidal/adverse effects ; Bradycardia/chemically induced ; Prednisolone/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Clinical statistical analysis plan for the ACCURE trial: the effect of appendectomy on the clinical course of ulcerative colitis, a randomised international multicentre trial.
Autorzy:
Visser E; Department of Surgery, Amsterdam University Medical Centre, Amsterdam, The Netherlands. .
Heuthorst L; Department of Surgery, Amsterdam University Medical Centre, Amsterdam, The Netherlands.
Pathmakanthan S; Department of Gastroenterology, Queen Elizabeth University Hospital Birmingham, Birmingham, UK.
Bemelman WA; Department of Surgery, Amsterdam University Medical Centre, Amsterdam, The Netherlands.
D'Haens GR; Department of Gastroenterology and Hepatology, Amsterdam University Medical Centre, Amsterdam, the Netherlands.
Handley K; University of Birmingham Clinical Trials Unit, Birmingham, UK.
Fakis A; Derby Clinical Trials Support Unit, University Hospitals of Derby and Burton NHS Foundation Trust, Derby, UK.
Pinkney TD; Academic Department of Surgery, University of Birmingham, Birmingham, UK.
Buskens CJ; Department of Surgery, Amsterdam University Medical Centre, Amsterdam, The Netherlands.
Dijkgraaf MGW; Department of Epidemiology and Data Science, University Medical Centre, Amsterdam, the Netherlands.; Methodology, Amsterdam Public Health, Amsterdam, the Netherlands.
Pokaż więcej
Źródło:
Trials [Trials] 2024 Mar 26; Vol. 25 (1), pp. 218. Date of Electronic Publication: 2024 Mar 26.
Typ publikacji:
Randomized Controlled Trial; Multicenter Study; Journal Article
MeSH Terms:
Colitis, Ulcerative*/drug therapy
Humans ; Appendectomy ; Quality of Life ; Remission Induction ; Neoplasm Recurrence, Local ; Mesalamine ; Recurrence ; Disease Progression
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Preparation and in-vitro evaluation of single and bi-layered beeswax-based microparticles for colon-specific delivery of mesalamine.
Autorzy:
BRAHMI, RYM
DIAF, KHEIRA
ELBAHRI, ZINEB
BAITICHE, MILAD
Pokaż więcej
Alternatywny tytuł:
ПРИПРЕМА И IN VITRO ЕВАЛУАЦИЈА ЈЕДНОСЛОЈНИХ И ДВОСЛОЈНИХ МИКРОЧЕСТИЦА НА БАЗИ ПЧЕЛИЊЕГ ВОСКА ЗА КОЛОН-СПЕЦИФИЧНУ ДОСТАВУ МЕСАЛАМИНА
Źródło:
Journal of the Serbian Chemical Society. 2024, Vol. 89 Issue 1, p91-106. 16p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Editorial: maternal and paternal 5-aminosalicylic acid use-safe in conception and pregnancy.
Autorzy:
Bennett A; Division of Gastroenterology and Hepatology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Horst S; Division of Gastroenterology and Hepatology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2022 Nov; Vol. 56 (9), pp. 1419-1420.
Typ publikacji:
Editorial; Comment
MeSH Terms:
Mesalamine*/therapeutic use
Pregnancy Complications*
Female ; Fertilization ; Humans ; Pregnancy
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Efficacy and safety of tacrolimus in older adults with ulcerative colitis: a retrospective study.
Autorzy:
Ito A; Department of Gastroenterology, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan. .
Murasugi S; Department of Gastroenterology, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan.
Omori T; Department of Gastroenterology, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan.
Nakamura S; Department of Gastroenterology, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan.
Tokushige K; Department of Gastroenterology, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan.
Pokaż więcej
Źródło:
BMC gastroenterology [BMC Gastroenterol] 2024 Jan 08; Vol. 24 (1), pp. 22. Date of Electronic Publication: 2024 Jan 08.
Typ publikacji:
Journal Article
MeSH Terms:
Colitis, Ulcerative*/drug therapy
Aged ; Humans ; Retrospective Studies ; Tacrolimus/adverse effects ; Mesalamine/adverse effects ; Albumins
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Involvement of Embryo-Derived and Monocyte-Derived Intestinal Macrophages in the Pathogenesis of Inflammatory Bowel Disease and Their Prospects as Therapeutic Targets.
Autorzy:
Zuo S; Institute of Clinical Pharmacology, Anhui Medical University, Key Laboratory of Anti-Inflammatory and Immune Medicine, Ministry of Education, Anhui Collaborative Innovation Center of Anti-Inflammatory and Immune Medicine, Hefei 230032, China.
Jiang L; Institute of Clinical Pharmacology, Anhui Medical University, Key Laboratory of Anti-Inflammatory and Immune Medicine, Ministry of Education, Anhui Collaborative Innovation Center of Anti-Inflammatory and Immune Medicine, Hefei 230032, China.
Chen L; Institute of Clinical Pharmacology, Anhui Medical University, Key Laboratory of Anti-Inflammatory and Immune Medicine, Ministry of Education, Anhui Collaborative Innovation Center of Anti-Inflammatory and Immune Medicine, Hefei 230032, China.
Wang W; Institute of Clinical Pharmacology, Anhui Medical University, Key Laboratory of Anti-Inflammatory and Immune Medicine, Ministry of Education, Anhui Collaborative Innovation Center of Anti-Inflammatory and Immune Medicine, Hefei 230032, China.
Gu J; Institute of Clinical Pharmacology, Anhui Medical University, Key Laboratory of Anti-Inflammatory and Immune Medicine, Ministry of Education, Anhui Collaborative Innovation Center of Anti-Inflammatory and Immune Medicine, Hefei 230032, China.
Kuai J; Institute of Clinical Pharmacology, Anhui Medical University, Key Laboratory of Anti-Inflammatory and Immune Medicine, Ministry of Education, Anhui Collaborative Innovation Center of Anti-Inflammatory and Immune Medicine, Hefei 230032, China.
Yang X; Institute of Clinical Pharmacology, Anhui Medical University, Key Laboratory of Anti-Inflammatory and Immune Medicine, Ministry of Education, Anhui Collaborative Innovation Center of Anti-Inflammatory and Immune Medicine, Hefei 230032, China.
Ma Y; Institute of Clinical Pharmacology, Anhui Medical University, Key Laboratory of Anti-Inflammatory and Immune Medicine, Ministry of Education, Anhui Collaborative Innovation Center of Anti-Inflammatory and Immune Medicine, Hefei 230032, China.
Han C; Institute of Clinical Pharmacology, Anhui Medical University, Key Laboratory of Anti-Inflammatory and Immune Medicine, Ministry of Education, Anhui Collaborative Innovation Center of Anti-Inflammatory and Immune Medicine, Hefei 230032, China.
Wei W; Institute of Clinical Pharmacology, Anhui Medical University, Key Laboratory of Anti-Inflammatory and Immune Medicine, Ministry of Education, Anhui Collaborative Innovation Center of Anti-Inflammatory and Immune Medicine, Hefei 230032, China.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Jan 05; Vol. 25 (2). Date of Electronic Publication: 2024 Jan 05.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Monocytes*
Inflammatory Bowel Diseases*/drug therapy
Inflammatory Bowel Diseases*/etiology
Humans ; Macrophages ; Mesalamine ; Anti-Inflammatory Agents ; Inflammation
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Alleviating effect of Nexrutine on mucosal inflammation in mice with ulcerative colitis: Involvement of the RELA suppression.
Autorzy:
Xu H; Graduate School, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, China.
Wu C; Department of Continuing Education, First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, China.
Wang D; Graduate School, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, China.
Wang H; Department of Liver, Spleen and Stomach, First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, China.
Pokaż więcej
Źródło:
Immunity, inflammation and disease [Immun Inflamm Dis] 2024 Jan; Vol. 12 (1), pp. e1147.
Typ publikacji:
Journal Article
MeSH Terms:
Colitis, Ulcerative*/chemically induced
Colitis, Ulcerative*/drug therapy
Plant Extracts*
Humans ; Animals ; Mice ; Mesalamine ; Cytokines ; Inflammation/drug therapy ; Transcription Factor RelA/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The long-term effect on surgery-free survival of biological compared to conventional therapy in Crohn's disease in real world-data: a retrospective study.
Autorzy:
Valvano M; Gastroenterology Unit, Division of Gastroenterology, Hepatology, and Nutrition, Department of Life, Health and Environmental Sciences, University of L'Aquila, Piazzale Salvatore Tommasi 1, 67100, L'Aquila, Italy. .
Vinci A; Hospital Health Management Area, Local Health Authority 'Roma 1', 00193, Rome, Italy.; University of Rome 'Tor Vergata', 00133, Rome, Italy.
Cesaro N; Gastroenterology Unit, Division of Gastroenterology, Hepatology, and Nutrition, Department of Life, Health and Environmental Sciences, University of L'Aquila, Piazzale Salvatore Tommasi 1, 67100, L'Aquila, Italy.
Frassino S; Gastroenterology Unit, Division of Gastroenterology, Hepatology, and Nutrition, Department of Life, Health and Environmental Sciences, University of L'Aquila, Piazzale Salvatore Tommasi 1, 67100, L'Aquila, Italy.
Ingravalle F; Hospital Health Management Area, Local Health Authority 'Roma 6', 00041, Albano Laziale, Italy.
Ameli M; Area Vasta (ASUR) 5; Ascoli Piceno - San Benedetto del Tronto, San Benedetto del Tronto, Italy.
Viscido A; Gastroenterology Unit, Division of Gastroenterology, Hepatology, and Nutrition, Department of Life, Health and Environmental Sciences, University of L'Aquila, Piazzale Salvatore Tommasi 1, 67100, L'Aquila, Italy.
Necozione S; Epidemiology Unit, Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.
Latella G; Gastroenterology Unit, Division of Gastroenterology, Hepatology, and Nutrition, Department of Life, Health and Environmental Sciences, University of L'Aquila, Piazzale Salvatore Tommasi 1, 67100, L'Aquila, Italy.
Pokaż więcej
Źródło:
BMC gastroenterology [BMC Gastroenterol] 2023 Dec 14; Vol. 23 (1), pp. 438. Date of Electronic Publication: 2023 Dec 14.
Typ publikacji:
Journal Article
MeSH Terms:
Crohn Disease*/drug therapy
Crohn Disease*/surgery
Crohn Disease*/diagnosis
Biological Products*/therapeutic use
Humans ; Retrospective Studies ; Italy/epidemiology ; Mesalamine/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Upadacitinib as a Rescue Therapy in Acute Severe Ulcerative Colitis: A Case Report and Review of the Literature.
Autorzy:
Ali NM; Department of Medicine, Mubarak AL-Kabeer Hospital, Haya Al-Habib Gastroenterology Center, Jabriya, Kuwait.
Shehab MA; Department of Medicine, Mubarak AL-Kabeer Hospital, Haya Al-Habib Gastroenterology Center, Jabriya, Kuwait.
Pokaż więcej
Źródło:
The American journal of case reports [Am J Case Rep] 2023 Nov 06; Vol. 24, pp. e940966. Date of Electronic Publication: 2023 Nov 06.
Typ publikacji:
Review; Case Reports; Journal Article
MeSH Terms:
Colitis, Ulcerative*/drug therapy
Colitis, Ulcerative*/surgery
Adult ; Female ; Humans ; Adolescent ; Infliximab/therapeutic use ; Heterocyclic Compounds, 3-Ring/therapeutic use ; Mesalamine ; Steroids/therapeutic use ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Randomised clinical trial and meta-analysis: mesalazine treatment in irritable bowel syndrome-effects on gastrointestinal symptoms and rectal biomarkers of immune activity.
Autorzy:
Castro Tejera V; Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Öhman L; Department of Microbiology and Immunology, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden.
Aabakken L; Department of Transplantation Medicine, Oslo University Hospital, Rikshospitalet, Norway.
Fellström B; Department of Medical Sciences, Uppsala University, Uppsala University Hospital, Uppsala, Sweden.
Hausken T; Department of Clinical Medicine, Haukeland University Hospital, University of Bergen, Bergen, Norway.
Hovde Ø; Department of Medicine, Innlandet Hospital Trust, Gjøvik, Norway.
Hreinsson JP; Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Lindberg G; Karolinska Institutet, Department of Medicine, Karolinska University Hospital Huddinge, Stockholm, Sweden.
Venge P; Department of Medical Sciences, Uppsala University, Uppsala University Hospital, Uppsala, Sweden.; Diagnostics Development, Uppsala, Sweden.
Simrén M; Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Center for Functional GI and Motility Disorders, University of North Carolina-Chapel Hill, Chapel Hill, North Carolina, USA.
Törnblom H; Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2022 Sep; Vol. 56 (6), pp. 968-979. Date of Electronic Publication: 2022 Aug 08.
Typ publikacji:
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't
MeSH Terms:
Irritable Bowel Syndrome*/drug therapy
Mesalamine*/therapeutic use
Biomarkers ; Clinical Protocols ; Double-Blind Method ; Humans ; Multicenter Studies as Topic ; Randomized Controlled Trials as Topic ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The insoluble excretion of multi-matrix system mesalazine preparations in patients with ulcerative colitis.
Autorzy:
Ohtaki Y; Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University Kashiwa Hospital, 163-1 Kashiwa, Kashiwa-shi, Chiba, 277-8567, Japan. .
Uchiyama K; Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University Kashiwa Hospital, 163-1 Kashiwa, Kashiwa-shi, Chiba, 277-8567, Japan. .
Kamiya H; Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University Kashiwa Hospital, 163-1 Kashiwa, Kashiwa-shi, Chiba, 277-8567, Japan.
Moriizumi E; Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University Kashiwa Hospital, 163-1 Kashiwa, Kashiwa-shi, Chiba, 277-8567, Japan.
Yamada M; Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University Kashiwa Hospital, 163-1 Kashiwa, Kashiwa-shi, Chiba, 277-8567, Japan.
Aoki Y; Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University Kashiwa Hospital, 163-1 Kashiwa, Kashiwa-shi, Chiba, 277-8567, Japan.
Watanabe T; Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University Kashiwa Hospital, 163-1 Kashiwa, Kashiwa-shi, Chiba, 277-8567, Japan.
Kiryu S; Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University Kashiwa Hospital, 163-1 Kashiwa, Kashiwa-shi, Chiba, 277-8567, Japan.
Suzuki S; Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University Kashiwa Hospital, 163-1 Kashiwa, Kashiwa-shi, Chiba, 277-8567, Japan.
Matsumoto Y; Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University Kashiwa Hospital, 163-1 Kashiwa, Kashiwa-shi, Chiba, 277-8567, Japan.
Ito Z; Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University Kashiwa Hospital, 163-1 Kashiwa, Kashiwa-shi, Chiba, 277-8567, Japan.
Ohkusa T; Department of Microbiota Research, Juntendo University Graduate School of Medicine, 2-1-1 Hongou, Bunkyo-ku, Tokyo, 113-8421, Japan.
Koido S; Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University Kashiwa Hospital, 163-1 Kashiwa, Kashiwa-shi, Chiba, 277-8567, Japan.
Saruta M; Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine, 3-19-18 Nishishinbashi, Minato-ku, Tokyo, 105-0003, Japan.
Pokaż więcej
Źródło:
BMC gastroenterology [BMC Gastroenterol] 2022 Aug 18; Vol. 22 (1), pp. 390. Date of Electronic Publication: 2022 Aug 18.
Typ publikacji:
Journal Article
MeSH Terms:
Colitis, Ulcerative*/chemically induced
Colitis, Ulcerative*/drug therapy
Mesalamine*/therapeutic use
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use ; Humans ; Retrospective Studies ; Sensitivity and Specificity
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Association between dietary acid load and the odds of ulcerative colitis: a case–control study.
Autorzy:
Movahedian, Mina (AUTHOR)
Emamat, Hadi (AUTHOR)
Tangestani, Hadith (AUTHOR)
Rashvand, Samaneh (AUTHOR)
Ghalandari, Hamid (AUTHOR)
Somi, Mohammad Hossein (AUTHOR)
Hekmatdoost, Azita (AUTHOR)
Pokaż więcej
Źródło:
Scientific Reports. 8/23/2023, Vol. 13 Issue 1, p1-7. 7p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Bickerstaff's brainstem encephalitis: a rare case of neurologic complication in Ulcerative Colitis.
Autorzy:
Joo H; Department of Neurology, Yonsei University College of Medicine, Gangnam Severance Hospital, Seoul, South Korea.
Lee CS; Department of Neurology, Yonsei University College of Medicine, Gangnam Severance Hospital, Seoul, South Korea.
Joe S; Department of Neurology, Yonsei University College of Medicine, Gangnam Severance Hospital, Seoul, South Korea.
Han J; Department of Ophthalmology, Yonsei University College of Medicine, Seoul, South Korea.
Kim HK; Department of Neurology, Yonsei University College of Medicine, Gangnam Severance Hospital, Seoul, South Korea. .
Cho H; Department of Neurology, Yonsei University College of Medicine, Gangnam Severance Hospital, Seoul, South Korea.
Pokaż więcej
Źródło:
BMC neurology [BMC Neurol] 2023 Oct 26; Vol. 23 (1), pp. 386. Date of Electronic Publication: 2023 Oct 26.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Colitis, Ulcerative*/complications
Colitis, Ulcerative*/pathology
Encephalitis*/complications
Encephalitis*/diagnosis
Ophthalmoplegia*
Autoimmune Diseases of the Nervous System*
Male ; Humans ; Middle Aged ; Brain Stem/diagnostic imaging ; Brain Stem/pathology ; Mesalamine ; Quadriplegia ; Ataxia/complications ; Gangliosides
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 2916

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies